[HTML][HTML] Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
MJ Mason, FA Sinicrope, AI Phipps, M Clendenning… - Annals of …, 2017 - Elsevier
Background TNM staging alone does not accurately predict outcome in colon cancer (CC)
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
[PDF][PDF] Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps… - Annals of …, 2017 - core.ac.uk
Background: TNM staging alone does not accurately predict outcome in colon cancer (CC)
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
[引用][C] Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps… - Annals of …, 2017 - cir.nii.ac.jp
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a
retrospective, pooled biomarker study | CiNii Research CiNii 国立情報学研究所 学術情報 …
retrospective, pooled biomarker study | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF][PDF] Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.
R Dienstmann, MJ Mason, FA Sinicrope… - Annals of …, 2017 - serval.unil.ch
TNM staging alone does not accurately predict outcome in colon cancer (CC) patients who
may be eligible for adjuvant chemotherapy. It is unknown to what extent the molecular …
may be eligible for adjuvant chemotherapy. It is unknown to what extent the molecular …
[PDF][PDF] Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason… - Annals of …, 2017 - minerva-access.unimelb.edu.au
Background: TNM staging alone does not accurately predict outcome in colon cancer (CC)
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
[引用][C] Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason, FA Sinicrope… - Annals of …, 2017 - espace.library.uq.edu.au
Background: TNM staging alone does not accurately predict outcome in colon cancer (CC)
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason… - … : official journal of …, 2017 - mayoclinic.elsevierpure.com
Results: TNM staging, MSI and BRAFV600E mutation status remained independent
prognostic factors in multivariable models across clinical trials cohorts and observational …
prognostic factors in multivariable models across clinical trials cohorts and observational …
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason, FA Sinicrope… - Annals of …, 2017 - annalsofoncology.org
Background TNM staging alone does not accurately predict outcome in colon cancer (CC)
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.
R Dienstmann, M Mason, FA Sinicrope, A Phipps… - Annals of …, 2017 - duo.uio.no
Background: TNM staging alone does not accurately predict outcome in colon cancer (CC)
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the …
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.
R Dienstmann, MJ Mason, FA Sinicrope… - Annals of oncology …, 2017 - sonar.ch
Results TNM staging, MSI and BRAFV600E mutation status remained independent
prognostic factors in multivariable models across clinical trials cohorts and observational …
prognostic factors in multivariable models across clinical trials cohorts and observational …